|
Volumn 55, Issue SUPPL. 1, 2006, Pages
|
Distinctions and contradistinctions between antiobesity histamine H 3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 [2 [2 (2 METHYLPYRROLIDIN 1 YL)ETHYL]BENZOFURAN 5 YL]BENZONITRILE;
4' [3 [3 (DIMETHYLAMINO) 1 PYRROLIDINYL]PROPOXY] 3' FLUORO 1,1' BIPHENYL 4 CARBONITRILE;
4' [3 [3 (DIMETHYLAMINO) 1 PYRROLIDINYL]PROPOXY] 3',5' DIFLUORO 1,1' BIPHENYL 4 CARBONITRILE;
4' [3 [3 (DIMETHYLAMINO) 1 PYRROLIDINYL]PROPOXY] 3',5' DIHYDRO 1,1' BIPHENYL 4 CARBONITRILE;
5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN;
A 331440;
A 417022;
A 423579;
A 631972;
CIPROXIFAN;
GUANOSINE 5' O (3 THIOTRIPHOSPHATE);
HISTAMINE H3 RECEPTOR ANTAGONIST;
PROTEIN C FOS;
RADIOLIGAND;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
COGNITION;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG POTENCY;
IMMUNOREACTIVITY;
MALE;
NONHUMAN;
OBESITY;
RAT;
ANIMALS;
ANTI-OBESITY AGENTS;
BRAIN;
COGNITION;
HISTAMINE ANTAGONISTS;
LIGANDS;
MALE;
MICE;
PROTO-ONCOGENE PROTEINS C-FOS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, HISTAMINE H3;
|
EID: 33646798771
PISSN: 10233830
EISSN: 1420908X
Source Type: Journal
DOI: 10.1007/s00011-005-0034-0 Document Type: Conference Paper |
Times cited : (13)
|
References (7)
|